Revisiting Methaqualone: Changes Made and Future Lessons Ignored

Methaqualone, a sedative-hypnotic drug, was legally available in the United States for less than twenty years. During that time, millions of doses were prescribed to patients and an untold number of pills were taken by recreational users. In what has become a common theme among many pharmaceutical p...

Full description

Saved in:  
Bibliographic Details
Authors: Griffin, O. Hayden (Author) ; Spillane, Joseph F. (Author)
Format: Electronic Article
Language:English
Published: 2022
In: American journal of criminal justice
Year: 2022, Volume: 47, Issue: 4, Pages: 749-769
Online Access: Volltext (lizenzpflichtig)
Journals Online & Print:
Drawer...
Check availability: HBZ Gateway
Keywords:

MARC

LEADER 00000naa a22000002 4500
001 1883304261
003 DE-627
005 20240313102149.0
007 cr uuu---uuuuu
008 240313s2022 xx |||||o 00| ||eng c
024 7 |a 10.1007/s12103-022-09700-w  |2 doi 
035 |a (DE-627)1883304261 
035 |a (DE-599)KXP1883304261 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 2,1  |2 ssgn 
100 1 |a Griffin, O. Hayden  |e VerfasserIn  |4 aut 
109 |a Griffin, O. Hayden 
245 1 0 |a Revisiting Methaqualone: Changes Made and Future Lessons Ignored 
264 1 |c 2022 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
520 |a Methaqualone, a sedative-hypnotic drug, was legally available in the United States for less than twenty years. During that time, millions of doses were prescribed to patients and an untold number of pills were taken by recreational users. In what has become a common theme among many pharmaceutical products, methaqualone sales and use were heavily influenced by a widespread and misleading marketing campaign. After methaqualone was placed into Schedule I of the Controlled Substances Act, in 1984, use of the drug diminished until methaqualone became essentially nonexistent in the United States. While some have concluded that the disappearance of methaqualone was a regulatory success, we argue that drug regulators myopically focused on methaqualone itself and did not give enough consideration to how other drugs could produce equal or greater levels of harm and no actions were taken to disincentivize and/or prevent the pharmaceutical industry from engaging in similar behaviors. 
650 4 |a Methaqualone 
650 4 |a OxyContin 
650 4 |a Quaaludes 
700 1 |a Spillane, Joseph F.  |e VerfasserIn  |0 (DE-588)1062598148  |0 (DE-627)805511091  |0 (DE-576)419958894  |4 aut 
773 0 8 |i Enthalten in  |t American journal of criminal justice  |d New York, NY [u.a.] : Springer, 1975  |g 47(2022), 4, Seite 749-769  |h Online-Ressource  |w (DE-627)545782163  |w (DE-600)2387971-3  |w (DE-576)306834987  |x 1936-1351  |7 nnns 
773 1 8 |g volume:47  |g year:2022  |g number:4  |g pages:749-769 
856 4 0 |u https://doi.org/10.1007/s12103-022-09700-w  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
ELC |a 1 
LOK |0 000 xxxxxcx a22 zn 4500 
LOK |0 001 4499819660 
LOK |0 003 DE-627 
LOK |0 004 1883304261 
LOK |0 005 20240313102318 
LOK |0 008 240313||||||||||||||||ger||||||| 
LOK |0 040   |a DE-2619  |c DE-627  |d DE-2619 
LOK |0 092   |o n 
LOK |0 852   |a DE-2619 
LOK |0 852 1  |9 00 
LOK |0 866   |x zotak: Nacherfasst, wegen zota-Pause 
LOK |0 935   |a krzo 
ORI |a SA-MARC-krimdoka001.raw